z-logo
Premium
Sinus‐like dilatations of the mammary milk ducts, Ki67 expression, and CD 3‐positive T lymphocyte infiltration, in the mammary gland of wild European rabbits during pregnancy and lactation
Author(s) -
Hughes Katherine,
Watson Christine J.
Publication year - 2018
Publication title -
journal of anatomy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.932
H-Index - 118
eISSN - 1469-7580
pISSN - 0021-8782
DOI - 10.1111/joa.12824
Subject(s) - myoepithelial cell , mammary gland , biology , lactation , cytokeratin , epithelium , immune system , pathology , medicine , pregnancy , immunology , immunohistochemistry , genetics , cancer , breast cancer
Sinus‐like dilatations of the mammary duct are recognisable in the mammary gland of pregnant and lactating wild European rabbits. These dilatations exhibit a bilaminar epithelial lining, with luminal epithelial cells expressing basal and lateral E‐cadherin. Occasional binucleated mammary epithelial cells are present in the luminal layer. Underlying the luminal epithelial cells is a basal layer of cytokeratin 14‐positive cells, supported by a thin layer of fibrous tissue. Multi‐segmental epithelial proliferation, as indicated by Ki67 expression, is apparent in the luminal epithelial cells, suggesting a capacity for division during pregnancy and lactation. CD 3‐positive T lymphocytes are present both intraepithelially, suggesting exocytosis, and in foci subjacent to the ductular epithelium. We consider that sinus‐like dilatations of the mammary duct may have the potential to give rise to a subset of the mammary gland neoplasms classified as ductal in origin. Milk accumulation in these sinus‐like dilatations is likely to provide a niche for bacterial replication in cases of mastitis in rabbits. These structures are an important component of the innate immune system of the mammary gland, both as a physical barrier and as an interface between the milk and mammary immune cells.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here